These special “meeting-within-a-meeting” tracks integrate focused discussions, oral and poster abstract sessions, and networking opportunities to provide you with the latest research in dedicated topic areas. To view the full listing, please visit the program planner.
Presidential Plenary: Big Data and the Future of Endocrine Research
- Precisely Practicing Medicine from 700 Trillion Points of Data
Atul J. Butte, MD, PhD—University of California, San Francisco, San Francisco, CA, USA
- Diabetes Research in the Era of Big Data: The NIDDK Perspective
Griffin P. Rodgers, MD—National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
Bridging the Translational Divide: Successes in Bench to Bedside
- The Incretin Revolution: Lizard Secrets and Peptide Innovation Change the Management of Diabetes
Daniel J. Drucker, MD, Lunenfeld-Tanenbaum Research Institute, University of Toronto Mt. Sinai Hospital, Toronto, Canada
- Genetic Protection from Lipid Accumulation: A Journey from Plaque to Pate
Helen H. Hobbs, MD, University of Texas Southwestern Medical Center, Dallas, TX, USA
Challenging the Dogma: Targeting Beta Cells in T1D Treatment
- Beta Cells in Type 1 Diabetes - Sleeping or Dead?
Carmella Evans-Molina, MD, PhD, Indiana University School of Medicine
- Preserving Beta Cell Function: Immunotherapies
Laura Jacobsen, MD, University of Florida
- Strategies to Preserve Residual Beta Cells in T1DM
Amelia K. Linnemann, PhD, Indiana University School of Medicine
The Failing Beta Cell in Type 2 Diabetes
- Therapeutic Human Beta Cell Proliferation: From Impossible to Possible
Andrew Stewart, MD, Icahn School of Medicine at Mount Sinai
- Dysregulation of Lipid Metabolism: Impacts on the Beta Cell in Type 2 Diabetes
Yumi Imai, MD, University of Iowa
- Omics to Novel Pathways in the Pancreatic Islet
Maike Sander, MD, University of California, San Diego
Liver Nuclear Receptors in Metabolic Homeostasis
- Regulation of alcohol and sweet preference and hydration by the metabolic stress hormone FGF21
Steven Kliewer, PhD, University of Texas Southwestern Medical Center
- Battle of The Sexes- Biliary Homeostasis and Hepatocellular Carcinomar
Sayeepriyadarshini Anakk, PhD, University of Illinois
- Circadian Nuclear Contenders in NASH and Hepatocellular Carcinoma
Kristin Eckel-Mahan, PhD, McGovern Medical School, University of Texas Health Science Center at Houston
Targeting Cancer-Anorexia in Obesity Treatment: GDF15 and Beyond
- CNS Mechanisms of Action of GDF15
Martin Myers, MD, PhD, University of Michigan
- Physiological role of GDF15 in energy metabolism
Christoffer Clemmensen, PhD, University of Copenhagen
- Therapeutic Potential of GDF15 for the Treatment of Obesity
Ruth Gimeno, PhD, Lilly Research Laboratories
Transcriptional Programming of Adipocyte Biology
- ChairsShingo Kajimura, PhD, Beth Israel Deaconess Medical Center; Hei Sul, PhD, University of California Berkeley
- Transcriptional Networks and Epigenomic Mechanisms Regulating human Mesenchymal Stem Cell Differentiation
Susanne Mandrup, PhD, University of Southern Denmark
- Novel Insights into Adipose Tissue Function
Evan Rosen, MD, PhD, Beth Israel Deaconess Medical Center
- Transcriptional and epigenomic control of adipose tissue homeostasis
Mitchell Lazar, MD, PhD, University of Pennsylvania
Understanding the Cellular Diversity of Adipocytes One by One
Functional Heterogeneity of White Adipocytes Within Single Fat Depots
Kevin Lee, PhD, Ohio University
Molecular and Functional Heterogeneity of Classical Brown Adipocytes
Qiong (Annabel) Wang, PhD, City of Hope National Medical Center
Functional Heterogeneity of Human Adipocytes
Silvia Corvera, MD, University of Massachusetts
What Does Your Gut Tell You? How the Microbiome Modulates Metabolism
- Multi-Omics Approaches Define New Regulatory Nodes in Cardiometabolic Disease Pathogenesis
Christopher Newgard, PhD, Duke University, Durham, NC, USA
- The Gut Microbiome: Connections Between Nutrient Sensing, Glucose, and Disease
Tony Lam, PhD, Toronto General Hospital and University of Toronto, Canada
Why Are ANGPTLs Important for Lipoprotein Pathophysiology and Atherosclerosis?
- ANGPTL Proteins and the Pathogenesis of Metabolic Disease
Brandon S. Davies, PhD, University of Iowa
- Molecular interplay between LPL, GPIHBP1 and ANGPTLs - when protein disorder regulates intravascular lipolysis
Michael Ploug, PhD, DSc, Finsen Laboratory & Biotech Research & Innovation Centre, Rigshospitalet and University of Copenhagen
- The role of ANGPTL4 in macrophages and adipocytes
Sander Kersten, PhD, Wageningen University
